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Abstract
Background: Malaria is often considered a cause of adult sepsis in malaria endemic areas. However, diagnostic
limitations can make distinction between malaria and other infections challenging. Therefore, the objective of this
study was to determine the relative contribution of malaria to adult sepsis in south-western Uganda.
Methods: Adult patients with sepsis were enrolled at the Mbarara Regional Referral Hospital between February and May
2012. Sepsis was defined as infection plus ≥2 of the following: axillary temperature >37.5°C or <35.5°C, heart rate >90 or
respiratory rate >20. Severe sepsis was defined as sepsis plus organ dysfunction (blood lactate >4 mmol/L,
confusion, or a systolic blood pressure <90 mmHg). Sociodemographic, clinical and laboratory data, including
malaria PCR and rapid diagnostic tests, as well as acid fast bacteria sputum smears and blood cultures were
collected. Patients were followed until in-patient death or discharge. The primary outcome of interest was the
cause of sepsis. Multivariable logistic regression was performed to assess predictors of mortality.
Results: Enrollment included 216 participants who were 51% female with a median age of 32 years (IQR 27–43 years).
Of these, 122 (56%) subjects were HIV-seropositive of whom 75 (66%) had a CD4+ T cell count <100 cells/μL. The
prevalence of malaria was 4% (six with Plasmodium falciparum, two with Plasmodium vivax). Bacteraemia was identified
in 41 (19%) patients. In-hospital mortality was 19% (n =42). In multivariable regression analysis, Glasgow Coma
Score <9 (IRR 4.81, 95% CI 1.80-12.8) and severe sepsis (IRR, 2.07, 95% CI 1.03-4.14), but no specific diagnoses were
statistically associated with in-hospital mortality.
Conclusion: Malaria was an uncommon cause of adult sepsis in a regional referral hospital in south-western Uganda.
In this setting, a thorough evaluation for alternate causes of disease in patients presenting with sepsis is recommended.
Keywords: Sepsis, Uganda, Africa, Malaria, Adult
Background
Severe sepsis is an important cause of death in sub-
Saharan Africa (SSA) where the global burden of lethal
infectious diseases is highest [1]. Due to resource limita-
tions, including lack of investigative laboratory capacity,
the aetiology of infections causing sepsis in this region is
frequently unknown leading to empirical antimicrobial
therapy. In malaria-endemic regions this frequently in-
cludes anti-malarial drugs. Although the majority of mal-
aria rests with children and pregnant women, prevalence
can also be high among non-pregnant adult populations,
p a r t i c u l a r l yi nt h o s ei n f e c t e db yH I V[ 2 - 6 ] .O n er e c e n t
report suggested that the prevalence of malaria in adults
is higher than previously thought [7]. However, inciden-
tal parasitaemia can occur in asymptomatic patients so
the contribution of parasitaemia to the course of severe
sepsis can be difficult to discern. Furthermore, malaria is
frequently over-diagnosed in areas such as Uganda with
limited laboratory infrastructure. This can lead to over-
treatment and development of resistance to antiparasitic
medications [8,9].
The time to the initiation of appropriate antimicrobial
therapy is an important determinant of the outcome
from severe sepsis [10]. On the other hand, indiscrimin-
ate use of antimicrobial therapy leads inexorably to anti-
microbial resistance. Therefore, it is critical to determine
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antimicrobial therapy according to microbiological test re-
sults. In malaria-endemic settings, a better understanding
of the contribution of malaria to severe sepsis would allow
tailored empirical antimicrobial therapy and avoid over-
or under-treatment of malaria. Therefore, the objective
of this study was to determine the contribution of mal-
aria to sepsis in adults admitted to a regional referral
hospital in south-western Uganda. Because rapid diag-
nostic tests (RDTs) have not been studied in adults with
sepsis, a secondary aim was to determine the sensitivity
and specificity of bedside malaria tests compared to a
polymerase chain reaction (PCR) confirmed malaria diag-
nosis in the setting of adult sepsis.
Methods
Site description
The study was conducted on the medical ward of Mbarara
Regional Referral Hospital (MRRH), which is the teaching
hospital for the Faculty of Medicine at the Mbarara
University of Science and Technology (MUST) and serves
a largely rural population of 1.2-2.5 million people from
surrounding districts in south-western Uganda. Mbarara
District has an average malaria prevalence of 4% in urban
areas and 23% in rural areas. The climate is tropical
with a bimodal rainfall pattern in September-January
and March-May, and an average precipitation of 1,200 mm
per annum [11].
Study population and definitions
Adult patients (age ≥18 years) admitted to the medical
ward during the study period from February-May 2012
were screened consecutively during the hours of 08.00-
0.00. Patients were included if they met criteria for sep-
sis which was defined by clinical suspicion of infection
and ≥2 of the following: axillary temperature >37.5°C
or <35.5°C, heart rate >90 beats/min, and respiratory
rate >20 breaths/min. White blood cell concentration
(WBC) was not included in the enrolment criteria due
to lack of immediate availability of results. Severe sepsis
was diagnosed in patients with evidence of end-organ
dysfunction (blood lactate >4 mmol/L, confusion, or a
systolic blood pressure <90 mmHg) [5]. Patients were
excluded if they required triage to a surgical or obstet-
rics and gynaecology ward. Patients or their attendant
(an accompanying family member or friend) provided
informed consent prior to their enrolment in the study.
All clinical and laboratory data were provided to the at-
tending medical team as soon as they were available.
Data collection
A structured questionnaire was administered to patients
or their attendants to collect the following data for each
participant: demographics, history of presenting symptoms,
and HIV serology status. Examination findings, including
vital signs and Glasgow Coma Scale (GCS), and in-hospital
mortality were also recorded. The study team followed each
patient until discharge or death, but medical management
was provided by the admitting medical team.
Laboratory investigations were obtained for each patient
at the time of enrolment including complete blood cell
concentration (Beckman Coulter, France), random blood
glucose (Accu-Chek portable glucose analyzer; Roche diag-
nostics, Germany), and whole blood lactate (Accutrend
Portable Lactate Analyzer; Sports Resource Group, USA).
Prior to antibiotic administration, a blood sample was
obtained aseptically and 10 mL was inoculated into brain
heart infusion broth in duplicates and incubated at 37°C at
the MUST Microbiology Laboratory. This laboratory is
enrolled in the International Organisation for Standardisa-
tion and maintained satisfactory performance throughout
the study period. Positive blood cultures were observed
for turbidity, a clot or haemolysis; Gram’s stain was
done after subculturing on blood agar, MacConkey, and
Chocolate agar plates for maximum recovery and mor-
phological identification of the organisms. The plates
were incubated at 37°C for 18-24 h aerobically and an-
aerobically for Chocolate agar. Blood cultures that did
not show turbidity were further incubated up to 10 days.
Biochemical identification of culture isolates was done
according to standard methods. Bacteraemia was defined
as bacterial isolation from one or more blood culture
bottles. Cultures growing coagulase-negative staphylo-
cocci were considered contaminated and not included
in the final analyses.
Patients with suspected tuberculosis had sputum obtained
for light-emitting diode fluorescent microscopy (LED-FM).
For patients whose HIV status was not known or docu-
mented at the time of admission, HIV counselling and
testing was provided according to national guidelines.
Accordingly, a rapid HIV test was done (Determine,
Abbott Laboratories, Tokyo, Japan) followed by a con-
firmatory test for initially positive results (Statpak, Chembio
Diagnostic Systems, Inc, Medford, USA). When the results
were conflicting, a tie-breaker (Unigold, Trinity Biotech plc,
Bray, Ireland) was used.
Malaria blood slides were evaluated via Field’s staining
as previously described [12]. For the purposes of quality
control, 10% of all slides and all positive slides were
double-read by a second experienced and blinded tech-
nician. Slides were also double-read in the case of a posi-
tive RDT result. In cases of discordant results between
two microscopists or between RDT result and micros-
copy an additional reading was performed by a third
microscopist and taken as the definitive microscopy re-
sult. A drop of blood was obtained by lancet for malaria
RDT according to manufacturer’s directions (SD Bioline
Malaria Ag Pf/Pan, Standard Diagnostics, Inc, Korea).
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identification of Plasmodium falciparum and Plasmodium
lactate dehydrogenase (pLDH) for identification of Plasmo-
dium vivax, Plasmodium ovale,a n dPlasmodium malariae.
Blood was also obtained by phlebotomy for PCR testing.
Venous blood (100–200 μL) was applied to Whatman FTA
Classic Filter paper cards (GE Healthcare Ltd, New Jersey,
USA) and left to air dry. These cards deactivate viral
DNA/RNA and preserve human and parasite DNA for
downstream analyses. DNA extractions were carried out
according to the manufacturer's instructions. Briefly, a disc
of 1.2 mm in diameter was punched from the centre of
each dried blood spotted card and washed three times with
Whatman FTA Purification Reagent, and twice with TE
buffer. This treated disc was then used directly in subse-
quent PCR analyses. Nested PCR was performed using
the primers and amplification conditions as previously
described [13]. Nested PCRs were performed initially to
screen for samples containing Plasmodium as described.
Species of Plasmodium in positive samples were deter-
mined in separate species-specific nest 2 reactions. The
resulting PCR products were visualized on 2% agarose
gels, with the presence or absence of a band with each
species primer pair indicative of the presence or absence
of that species in the initial sample. The laboratory tech-
nicians performing PCR were blinded to the results of
blood smears and RDTs.
Statistical analysis
Demographic, clinical and laboratory characteristics of
the cohort were summarized. For the primary outcome
of interest, the relative contribution of etiologies of sep-
sis was measured. The causes of sepsis were defined as
either definitive or presumptive. Definitive causes were
tuberculosis identified by sputum LED-FM, culture-proven
bacteraemia, and malaria, as determined by a positive PCR.
Presumptive causes of sepsis included malaria (peripheral
blood smear or RDT), tuberculosis, community acquired
pneumonia, enteric fever, fever of unknown origin and
other or unspecified diagnosis. χ
2 testing was used to com-
pare baseline characteristics between those with and with-
out a definitive diagnosis of malaria. Poisson regression
models were fitted to determine factors associated with
incident hospital mortality, including demographic char-
acteristics, presenting signs, laboratory results, and dis-
charge diagnoses. Finally, multivariable Poisson regression
models which included all the characteristics that were
significant in univariable models as determined by a
p-value <0.25 were performed.
Ethics statement
Approval was obtained from the institutional review boards
of MUST and the University of Virginia prior to the begin-
ning of enrolment in this study.
Results
Cohort characteristics
A total of 646 patients were screened and 216 were en-
rolled (Figure 1). Their median age was 32 years (range
27-42 years) and approximately half were women (Table 1).
HIV-infection was present in 56% (122 of 216) of the co-
hort and 36% (44 of 122) were receiving antiretroviral
therapy (Table 2). Of those patients who had a CD4+
T cell test performed, 66% (75 of 113) had a CD4+ T-cell
concentration <100 cells/μL .T h em a j o r i t yo fp a t i e n t s
(90%, 194 of 216) complained of fever. Other common
complaints included cough (54%, 117 of 216), vomiting
(19%, 40 of 216), headache (12%, 26 of 216), and diarrhoea
(12%, 25 of 216). Prior to admission, 24% (51 of 216) of
patients had received antibiotics and 36% (77 of 216) had
received an anti-malarial drug including artemether-
lumefantrine (24%, 52 of 216) and quinine (16%, 35
of 216).
Clinical and laboratory characteristics
The majority of patients were febrile with a tempera-
ture >38°C (71%, 153 of 216), tachycardic with a heart rate
of ≥100 beats/min (82%, 177 of 216), and tachypneic with
a respiratory rate >20 breaths/min (96%, 208 of 216). Half
the patients (50%, 106 of 216) had severe sepsis with evi-
dence of end-organ dysfunction. Only 4% (8 of 216) of pa-
tients had PCR proven malaria whereas bacteraemia was
detected in 19% (41 of 216) of patients and 11% (24 of
216) had tuberculosis as defined by positive sputum LED-
FM. The most common presumptive diagnosis at dis-
charge was tuberculosis (28%, 61 of 216) followed by
pneumonia (26%, 56 of 216; Table 3). Of those with posi-
tive blood cultures, Staphylococcus aureus was the most
frequently identified pathogen (66%, 27 of 41) followed by
Salmonella species (20%, 8 of 41) and streptococcal
species (7%, 3 of 41). Laboratory evaluation revealed
leukocytosis (WBC count >12,000/ml) in 11% (24 of
215), anaemia (haemoglobin <9 mg/dL) in 43% (93 of
216) and thrombocytopenia (platelets <150 cells/μL)
in 55% (118 of 215) of participants. Lactic acidosis
(lactate >4 mmol/L) was identified in 42% (89 of 211)
of patients.
Total admissions screened 
N = 646 
Total eligible 
N = 262 
Not eligible, N = 384 
Not sepsis, N = 355 
Age < 18, N = 29 
Total enrolled 
N = 216 
Not enrolled, N = 46 
Declined, N = 30 
Unable, N = 12 
Readmitted, N = 3 
Transferred, N = 1 
Figure 1 Flow diagram of patient enrolment for the study.
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Malaria was identified by PCR in eight patients. There
were six cases of P. falciparum and two cases of P. vivax
infection. RDT and blood slide identified five and two of
these eight patients respectively. A positive RDT result
was 62.5% (95% CI 24.5-91.5) sensitive and 99.5% (95%
CI 97.3-100) specific for PCR proven malaria with an
83.3% positive predictive value and 98.6% negative pre-
dictive value. The sensitivity and specificity of a positive
Table 1 Summary statistics regarding demographics and
clinical characteristics for a cohort of adult patients
presenting with sepsis to a regional referral hospital in
south-western Uganda (n =216)
Characteristic Summary statistic
Demographics
Age (median, IQR) 32 (27 – 42)
Female, n (%) 110 (51)
Married, n (%) 123 (57)
Educational attainment, n (%)
None 59 (27)
Primary 121 (56)
Secondary 32 (15)
Tertiary 4 (2)
District of residence, n (%)
Mbarara 72 (33)
Isingiro 48 (22)
Kiruhura 28 (13)
Other 67 (31)
Clinical characteristics
Past medical history, n (%)
None 193 (90)
Diabetes mellitus 6 (3)
Kaposi’s Sarcoma 6 (3)
Other 10 (5)
Presenting symptoms, n (%)
Fever 194 (90)
Cough 117 (54)
Vomiting 40 (19)
Headache 26 (12)
Diarrhoea 25 (12)
Weight Loss 17 (8)
Dyspnea 15 (7)
Nightsweats 13 (6)
Medications prior to admission, n (%)
Antibiotics 51 (24)
Artemether/lumafantrine 52 (24)
Quinine 35 (16)
Presenting signs, n (%)
Fever (>38°C) 153 (71)
Tachycardia (100 beats/min) 177 (82)
Tachypnea (>20 breaths/min) 208 (96)
Hypotension (MAP<65) 62 (29)
Glasgow Coma Score <9 8 (4)
Severe Sepsis 106 (50)
Table 2 Summary statistics regarding test results and
hospital treatments for a cohort of adult patients
presenting with sepsis to a regional referral hospital in
south-western Uganda (n =216)
Characteristic Summary statistic
Test results, n (% positive)
Anaemia (haemoglobin <9 mg/dl) 93 (43)
Leukocytosis (WBC >12,000/μL) 24 (11)
Thrombocytopenia (platelets<150/μL) 118 (55)
Lactic Acidosis (lactate >4 mmol/L) 89 (42)
Positive Blood Culture, n (%) 41 (19)
Staphylococcus aureus 27 (66)
Salmonella spp. 8 (20)
Streptococcus spp. 3 (7)
Other/unidentified organism 3 (7)
HIV seropositive with positive blood cultures, n (%) 19 (9)
Staphylococcus aureus 17 (89)
Salmonella spp. 1 (5)
Other/unidentified organism 1 (5)
HIV seronegative or serostatus unknown with
positive blood cultures, n (%)
22 (10)
Staphylococcus aureus 10 (45)
Salmonella spp. 7 (32)
Streptococcus spp. 3 (14)
Other/unidentified organism 2 (9)
HIV seropositive, n (%) 122 (56)
CD4 count <100 cells/μL 75 (66)
ART prior to admission 44 (36)
Cotrimoxazole prior to admission 80 (66)
Malaria test n (% positive) 9 (4)
Positive malaria smear 2 (1)
Positive malaria rapid diagnostic test 6 (3)
Positive malaria PCR 8 (4)
Positive acid-fast bacteria sputum stain, n (%) 24 (11)
Hospital treatments received, n (%)
Artemether/lumafantrine 33 (15)
Quinine 45 (21)
Antibiotics 187 (87)
Anti-tuberculosis medicines 16 (7)
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(95% CI 3.2-65.1) and 100% (95% CI 98.2-100) respectively
with a positive predictive value of 100% and negative pre-
dictive value of 97.2%. A clinical discharge diagnosis of
malaria was 62% (95% CI 24.5-91.5) sensitive and 99.5%
(95% CI 97.3-100) specific for PCR proven malaria.
Due to the low prevalence of malaria in the cohort,
clinical correlates associated with malaria were difficult
to determine; however, cough was less common in those
with malaria (13%, 1 of 8 vs 56%, 116 of 208 in patients
without malaria, p=0.02). A final clinical discharge diag-
nosis of malaria was given to 50% (4 of 8) of patients
with malaria compared to 7% (14 of 208) in those with-
out malaria (p <0.01). Anti-malarial treatment was pro-
vided to 63% (5 of 8) of patients with malaria and 23%
(48 of 208) of those without malaria (p=0.01). Antibac-
terial therapy was provided to 63% (five of eight) and
88% (182 of 208) of patients with and without malaria
respectively (p=0.05).
Outcomes
The median length of stay was five days (IQR 3-8, range
0-41 days) and in-hospital death occurred in 19% (42 of
216) of the cohort. Among those with a definitive diag-
nosis of sepsis, mortality was 26.8% in those with bacter-
aemia, 25% for those with LED-FM sputum positive
tuberculosis, and 12.5% in those with malaria. Mortality
rates for those with presumptive diagnoses were 24.6%
for tuberculosis, 23.5% for fever of unknown origin,
21.5% for an unknown diagnosis, 12.5% for communi-
ty acquired pneumonia, 11.1% for malaria, and 10.5%
for enteric fever (Table 3). In the univariable analysis,
GCS <9, severe sepsis, and lactate >4 mmol/L were all
significantly associated with in-hospital mortality while
fever was associated with survival (p <0.05; Table 4). In
the multivariable regression model, the adjusted relative
risk (RR) for in-hospital mortality associated with a GCS
<9 was 4.8 with a 95% confidence interval (CI) of 1.8-
12.8 and p <0.01. Severe sepsis was also independently
associated with in-hospital mortality (RR 2.1, 95% CI
1.0-4.1, p=0.04). Lactate was removed from the multi-
variable model due to collinearity with severe sepsis.
In contradistinction, fever was independently associ-
ated with reduced in-hospital mortality (RR 0.5, 95% CI
0.2-0.9, p=0.02).
Discussion
In adult patients presenting to a regional referral hospital
in south-western Uganda where malaria transmission is
moderate, malaria was an uncommon cause of sepsis.
These findings have implications for empirical treatment
of sepsis in this region and emphasize the importance of
the determination of microbiological diagnoses when
treating sepsis. Based on these data, malaria as a sole cause
of sepsis should be considered a diagnosis of exclusion
among patients presenting with sepsis in similar settings.
Accordingly, since the negative predictive value of RDT is
so high treatment for malaria should be limited to those
in whom malaria diagnosis has been made through a
positive RDT.
The low malaria prevalence of approximately 4% in
this cohort of adult patients with sepsis contrasts with
national Ugandan malaria epidemiology. As a whole,
Uganda has a high malaria prevalence (30-50%) which
may be increasing [14]. Additionally, annual entomological
inoculation rates (EIRs) vary in Uganda from four infective
bites per person year in the south-western highlands to >
1,500 infective bites per person per year in Apac in the
central part of the country [15]. Malaria admissions in-
creased in children in Uganda from 1999 until 2009 but
similar data are not available for adults [15]. In contrast to
the rest of the country, Mbarara District has had a
Table 3 Discharge diagnoses and outcomes among patients presenting with sepsis to a regional referral hospital in
south-western Uganda
Diagnosis at discharge, n (%) Length of stay Median (IQR) Mortality rate %
Total cohort 216 (100) 5 (3 – 8) 20.0
Definitive diagnosis
Malaria 8 (3) 4 (3 – 4.5) 12.5
Bacteraemia 41 (19) 5.5 (3 – 8.5) 26.8
Pulmonary tuberculosis 24 (11) 5.5 (2.5 – 13.5) 25.0
Presumptive diagnosis
Malaria 18 (8) 3 (2 – 5) 11.1
Tuberculosis 61 (28) 7 (4 – 11) 24.6
Enteric fever 19 (9) 4 (4 – 10) 10.5
Community acquired pneumonia 56 (26) 4 (3 – 6) 12.5
Fever of unknown origin 17 (8) 6 (3 – 12) 23.5
Other diagnosis, or unspecified 65 (30) 5 (3 – 9) 21.5
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with sepsis (Multivariable regression model adjusted for predictors of mortality that met inclusion by a p-value <0.25
in the univariable model)
Characteristic Incidence of
mortality
Incidence
rate ratio
95% CI p-value Adjusted incidence
rate ratio
95% CI p-value
Entire cohort 19.4 –– –
Age (each 10 years) – 1.02 0.84 – 1.27 0.78 –
Male (REF) 24.5
Female 14.6 0.59 0.32 – 1.11 0.10* 0.57 0.29 – 1.10 0.10
Single (REF) 22.0 –
Married 17.9 0.81 0.44 – 1.49 0.51
Educational attainment
Less than primary (REF) 17.8
Greater than primary 27.8 1.56 0.77 – 3.18 0.22* 1.45 0.70 – 3.03 0.32
Clinical characteristics
No antibiotics prior (REF) 18.8 –
Antibiotics prior 21.6 1.15 0.58 – 2.28 0.69
No fever (REF) 31.8
Fever 14.4 0.45 0.25 – 0.83 0.01* 0.46 0.24 – 0.88 0.02
No tachycardia (REF) 23.1 –
Tachycardia 18.6 0.81 0.39 – 1.69 0.57
No tachypnea (REF) 12.5 –
Tachypnea 19.7 1.57 0.22 – 11.46 0.65
No hypotension (REF) 19.5 –
Hypotension 19.4 0.99 0.51 – 1.94 0.99
GCS >9 (REF) 17.1
Glasgow Coma Score <9 75.0 4.39 1.85 – 10.44 <0.01* 4.81 1.80 – 12.8 <0.01
Sepsis (REF) 11.2
Severe sepsis 27.4 2.44 1.24 – 4.78 0.01* 2.07 1.03 – 4.14 0.04
No aenemia (REF) 21.3 –
Anaemia 17.2 0.81 0.43 – 1.50 0.50
No leuckocytosis (REF) 18.3 –
Leukocytosis 29.2 1.59 0.71 – 3.58 0.26
No thrombocytopaenia (REF) 17.5 –
Thrombocytopaenia 21.2 1.21 0.65 – 2.24 0.55
No lactic acidosis (REF) 13.1 –
Lactic acidosis 28.1 2.14 1.14 – 4.01 0.02*
HIV seronegative (REF) 19.2 –
HIV seropositive 19.7 1.03 0.56 – 1.89 0.93
Definitive diagnosis at discharge
Negative blood culture (REF) 17.9
Positive blood culture 26.8 1.50 0.75 – 2.98 0.25* 1.40 0.68 – 2.87 0.36
Negative or no sputum smear for AFB (REF) 18.8 –
Positive AFB sputum smear 25.0 1.33 0.56 – 3.16 0.51
No confirmed malaria (REF) 19.1 –
Confirmed malaria 33.3 1.75 0.43 – 7.24 0.44
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pending on the area within the district and the amount of
rainfall, Mbarara has an EIR of 11-100/year and a preva-
lence of 4-23% [11,14].
The reason for the low malaria prevalence in this co-
hort compared to the general population may be due to
several factors. First, epidemiological data are generally
derived from children as adults have improved immuno-
logical control of malaria and therefore lower prevalence
of infection even in the setting of HIV infection [2]. Se-
vere malaria may occur more often in adults who have
waxing and waning immunity to malaria where malaria
transmission is unstable and prone to epidemics, such as
the highlands of south-western Uganda which does not
include Mbarara District [16]. Second, many of the
patients (40%) had already received anti-malarial therapy
prior to admission. Therefore, any incidental parasitaemia
that was present in these patients was likely eradicated
prior to admission.
The RDT used in this study employed HRP-II to
identify Plasmodium falciparum and pLDH to identify
non-falciparum species. HRP-II antigen tests are very
sensitive and positive results can persist 14 days or
more after treatment whereas pLDH provides a negative
RDT result within 3 days of treatment [17,18]. There were
only 6 positive RDT results in this study. If malaria was a
significant cause of sepsis then more positive RDT results
would be expected despite any preceding anti-malarial
therapy. It cannot be completely ruled out that some of
the patients already on treatment could have been falsely-
negative for malaria by RDT, but these cases should have
been captured by the more sensitive PCR test. Although
microscopy and the degree of parasitaemia are more cor-
related with clinical symptoms, PCR was chosen as the
gold-standard in this study in order to apply the most sen-
sitive method to detect malaria parasitaemia. The use of
PCR allowed capture of the rare patient that had malaria
but had pre-hospital anti-malarial treatment and a subse-
quently negative malaria slide or RDT result.
A diagnosis of malaria was not associated with in-
creased mortality in this study or in similar studies.
Moreover, in contrast to receipt of early antibacterial
therapy, receipt of anti-malarial drugs did not improve
mortality outcomes in this study or a study of fluid re-
suscitation in severe sepsis performed in Uganda [19]. In
a study performed in a high malaria prevalence area of
Tanzania, malaria was not a frequent cause of severe
febrile illness in adults [20]. That study used RDTs and
blood smears but not PCR to define the presence of
malaria parasitaemia. Taken together, the results of this
study suggest that parasitaemia occurs very rarely in
this patient population and that malaria is infrequently
a cause of adult sepsis.
This and prior studies of severe sepsis in Uganda have
revealed non-Typhi Salmonella, Streptococcus pneumoniae,
and Staphylococcus aureus as common pathogens [5,19,21].
A close temporal association between bacteraemia and
malaria has also recently been made clear [22]. There
were no cases of dual infection in the current study.
However, pre-hospitalization use of antibacterial drugs
may have obscured the ability to detect bacteria in blood
cultures for some patients in this study. Tuberculosis
was a leading discharge diagnosis for this cohort and
was associated with approximately 25% mortality. Other
studies in SSA have documented Mycobacterium tuber-
culosis (MTb) as a common cause of bloodstream infec-
tion in hospitalized patients and these patients have
high mortality with 50% of patients dying within 36 days
Table 4 Incidence of mortality in adult patients presenting to the medical ward at Mbarara Regional Referral Hospital
with sepsis (Multivariable regression model adjusted for predictors of mortality that met inclusion by a p-value <0.25
in the univariable model) (Continued)
Clinical diagnosis at discharge
Not malaria (REF) 20.2 –
Malaria 11.1 0.55 0.13 – 2.28 0.41
Not tuberculosis (REF) 17.4 –
Tuberculosis 24.6 1.41 0.75 – 2.65 0.28
Not enteric fever REF) 20.3 –
Enteric fever 10.5 0.52 0.12 – 2.15 0.36
Not pneumonia (REF) 21.9 –
Pneumonia 12.5 0.57 0.24 – 1.29 0.18
Not fever of unknown origin (REF) 19.1 –
Fever of unknown origin 23.5 1.23 0.44 – 3.45 0.69
No other diagnosis (REF) 18.5 –
Other diagnosis, or unspecified 21.5 1.16 0.61 – 2.21 0.65
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that antituberculous drugs are included in empiric sep-
s i st h e r a p yi nM T be n d e m i cr e g i o n ss u c ha sU g a n d a .
Further investigation into MTb rapid diagnostics and
empirical anti-MTb therapy in the setting of sepsis in
this region are needed [24]. In this study, patients with
altered mental status and severe sepsis were at highest
risk of death. This is consistent with prior work from
the same institution and others in the region [5,19,21].
There are several limitations of this study. Patients
were not evaluated through an entire calendar year and
times of high malaria transmission may have been
missed. The enrolment period for this study did include
one of the rainiest times of year in Mbarara (March-
May) which accordingly is a time of high community
malaria prevalence [11]. Therefore, it is unlikely that
malaria prevalence in adult patients admitted with sepsis
would be higher at any other time. However, enrolment
of adult septic patients throughout a calendar year might
provide additional information on temporal changes in
malaria prevalence. Due to the small number of patients
with PCR proven malaria in this study, it is not possible
to draw definitive conclusions regarding the relative abil-
ities of blood slides and RDTs to diagnose malaria in
adult septic patients. These data do suggest that a posi-
tive finding by either modality is specific for malaria. Be-
yond malaria diagnostics, the ability to determine the
aetiology of sepsis in these patients was limited. Given
the high prevalence of mycobacteraemia that has re-
cently been described in similar patients in SSA it is
likely that many of these patients were infected with
MTb [19,23]. This conjecture is supported by the large
proportion of patients that were assigned a presumptive
(28%) or definitive (11%) discharge diagnosis of tuberculosis.
Additionally, it was not possible to detect rickettsial dis-
eases, Q-fever, leptospirosis, brucellosis, or histoplasmosis,
which have recently been increasingly recognized in the
region [25-28].
Despite these limitations, data from this study lend
strong support to the notion that malaria is an uncom-
mon cause of sepsis in adult inpatients in south-western
Uganda. Based on the findings of this study, the follow-
ing recommendations are made to practitioners provid-
ing care to patients with sepsis in similar settings. First,
thorough diagnostic evaluations should be pursued where
possible to evaluate for non-malarial causes of sepsis. Sec-
ond, as recommended by the World Health Organization,
anti-malarial therapy should be reserved for patients
with a positive RDT or blood slide result to minimize
over-prescribing and development of resistance. A bac-
terial cause of sepsis was identified in ~20% of these
patients and it is suggested that empirical treatment of
sepsis in this region should include coverage of staphylo-
cocci, streptococci, and Salmonella species. Unfortunately,
the vast majority of patients did not have a confirmed
microbiological diagnosis for their sepsis. Further studies
are needed to discern the role for empirical anti-MTb
therapy in patients presenting with sepsis in high HIV
prevalent MTb endemic areas. Improved diagnostic cap-
acity, including development of point-of-care testing, for
use in regional referral hospitals in resource-limited set-
tings may improve targeted and empirical therapy for
sepsis, reduce development of resistance to anti-malarial
agents, and improve outcomes. Finally, given the high
prevalence of HIV in this region all patients admitted
with sepsis should be tested for HIV according to na-
tional guidelines.
Conclusions
In Mbarara which is located south-western Uganda and
where community malaria prevalence is 4-23% malaria
was an infrequent cause of sepsis in adults. The ability
to detect parasitaemia was maximized through use of
PCR technology. Using this sensitive laboratory method,
only 8 out of 216 patients were diagnosed with malaria.
In contrast, bacteraemia was found in 41 (19%) patients.
Additionally, tuberculosis was a definitive diagnosis for
24 (11%) and presumptive diagnosis for 61 (28%) of these
patients. When treating adult septic patients in similar
regions a thorough evaluation of non-malaria diagnoses
with particular emphasis on identifying bacteraemia and
tuberculosis is recommended.
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